Obesity and cholangiocarcinoma
1Center for Endoscopy and Pancreatobiliary Disorders, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH 44195, USA. parsim@ccf.org
World Journal of Gastroenterology
|February 6, 2013
Summary
Obesity, a growing global health issue, is linked to various diseases. This review explores the potential connection between obesity and cholangiocarcinoma (bile duct cancer), a rare but lethal condition.
Area of Science:
- Public Health
- Oncology
- Epidemiology
Background:
- Obesity is a widespread health concern in developed and developing nations, associated with numerous chronic diseases.
- Cholangiocarcinoma (bile duct cancer) is a rare but highly lethal malignancy with increasing incidence in Western countries.
- Early diagnosis is challenging, making prevention a critical focus for improving patient outcomes.
Purpose of the Study:
- To summarize current research on the relationship between obesity and cholangiocarcinoma.
- To investigate obesity as a potential risk factor for bile duct cancer.
- To highlight the clinical and societal implications of this association.
Main Methods:
- Literature review of studies examining obesity and cholangiocarcinoma incidence.
- Analysis of epidemiological data and risk factors.
- Synthesis of existing scientific knowledge.
Main Results:
- Obesity is linked to increased risks of several chronic diseases and cancers.
- Emerging data suggests a potential rise in cholangiocarcinoma incidence, possibly influenced by increasing obesity rates.
- Further research is needed to establish a definitive causal link.
Conclusions:
- Obesity may be a modifiable risk factor for cholangiocarcinoma.
- Understanding this link is crucial for public health strategies and cancer prevention.
- Continued investigation into the obesity-cholangiocarcinoma relationship is warranted.
Related Concept Videos
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
